Posts Tagged ‘united’
Training in childhood obesity management in the United States: a survey of pediatric, internal medicine-pediatrics and family medicine residency program directors
Background:
Information about the availability and effectiveness of childhood obesity training during residency is limited.
Methods:
We surveyed residency program directors from pediatric, internal medicine-pediatrics (IM-Peds), and family medicine residency programs between September 2007 and January 2008 about childhood obesity training offered in their programs.
Results:
The response rate was 42.2% (299/709) and ranged by specialty from 40.1% to 45.4%. Overall, 52.5% of respondents felt that childhood obesity training in residency was extremely important, and the majority of programs offered training in aspects of childhood obesity management including prevention (N=240, 80.3%), diagnosis (N=282, 94.3%), diagnosis of complications (N=249, 83.3%), and treatment (N=242, 80.9%). However, only 18.1% (N=54) of programs had a formal childhood obesity curriculum with variability across specialties. Specifically, 35.5% of IM-Peds programs had a formal curriculum compared to only 22.6% of pediatric and 13.9% of family medicine programs (p<0.01). Didactic instruction was the most commonly used training method but was rated as only somewhat effective by 67.9% of respondents using this method. The most frequently cited significant barrier to implementing childhood obesity training was competing curricular demands (58.5%).
Conclusions:
While most residents receive training in aspects of childhood obesity management, deficits may exist in training quality with a minority of programs offering a formal childhood obesity curriculum. Given the high prevalence of childhood obesity, a greater emphasis should be placed on development and use of effective training strategies suitable for all specialties training physicians to care for children.
First Results In United States In 20 Years From Clinical Trials Of Smoked Cannabis
Researchers from the University of California’s Center for Medicinal Cannabis Research (CMCR) have found “reasonable evidence that cannabis is a promising treatment” for some specific, pain-related medical conditions. Their findings, presented to the California legislature and public, are included in a report available on the CMCR web site at http://www.cmcr.ucsd.edu…
Discrimination against international medical graduatesin the United States residency program selection process
Background:Available evidence suggests that international medical graduates have improved the availability of U.S. health care while maintaining academic standards. We wondered whether studies had been conducted to address how international graduates were treated in the post-graduate selection process compared to U.S. graduates.Methods:We conducted a Medline search for research on the selection process.Results:Two studies provide strong evidence that psychiatry and family practice programs respond to identical requests for applications at least 80% more often for U.S. medical graduates than for international graduates. In a third study, a survey of surgical program directors, over 70% perceived that there was discrimination against international graduates in the selection process.Conclusions:There is sufficient evidence to support action against discrimination in the selection process. Medical organizations should publish explicit proscriptions of discrimination against international medical graduates (as the American Psychiatric Association has done) and promote them in diversity statements. They should develop uniform and transparent policies for program directors to use to select applicants that minimize the possibility of non-academic discrimination, and the accreditation organization should monitor whether it is occurring. Whether there should be protectionism for U.S. graduates or whether post-graduate medical education should be an unfettered meritocracy needs to be openly discussed by medicine and society.
SUMAVEL(TM) DosePro(TM) Available In The United States To Treat Acute Migraine And Cluster Headaches
Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company, and Astellas Pharma U.S., Inc. (“Astellas”) announced the U.S. commercial launch of SUMAVEL? DosePro? (sumatriptan injection) needle-free delivery system. In July 2009, the U.S…
Severity Of Swine Flu In The United States
Research published this week in PLoS Medicine presents the most accurate assessment to date of the severity of the swine flu (H1N1) pandemic in the US. Scientists need to measure the severity of swine flu (how often infection with the swine flu virus results in symptoms leading to illness, hospitalization or death) so that appropriate pandemic plans can be put into place…
United States In “Good Shape” For Flu Season, Says MIT Sloan Expert
An MIT Sloan School of Management expert on U.S. vaccine markets is “cautiously hopeful” that public and private sector players are far better prepared for North America’s upcoming flu season than they have been for earlier flu pandemics. “Regulators, vaccine manufacturers, and public health agencies have been working very hard at coordination, both domestically and globally,” said MIT Sloan Professor Ernst R.
Total Swine Flu A(H1N1) Human Infection Cases Reach 7,447 In The United Kingdom
The Health Protection Agency (HPA), UK, informed yesterday 3rd July, 2009, in its weekly update that the total number of confirmed human cases of Swine Flu A(H1N1) infection has reached 7,447. British health authorities estimate that the figure will be over 100,000 by the end of this summer.
Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
German pain expert company Grünenthal GmbH announces that the new centrally acting analgesic tapentadol is now available in the United States. The drug is indicated for the relief of moderate to severe acute pain in patients 18 years of age and older. Approval was given by the US Food and Drug Administration (FDA) in November 2008 for tapentadol (NUCYNTATM) tablets. With the cooperation of Grünenthal and its marketing partner Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Swine Flu Leaflet To Be Sent To Every Household In The United Kingdom
The UK government has announced that every household in the United Kingdom will receive a leaflet which has important information on swine flu. So far (2nd May, 2009) there have been 11 reported cases of human swine flu infection in the UK. Below is the text of the leaflet. WHAT IS THIS LEAFLET FOR? The UK governments have produced this leaflet to give you information about swine flu. It tells you: What swine flu is and how it could spread.
United Healthcare Oxford Medicare Advantage Denies Coverage
 |
ABC NEWS/GOOD MORNING AMERICA:Senior With Fractured Back Battles UnitedHealthcare Oxford Health Insurance Company Medicare Advantage Plan GMA segment shows UnitedHealthcare/Oxford's Medicare Advantage Plan would not authorize woman's care due to alleged age discrimination.Audit shows Medicare Advantage providers with backlogs of unanswered patient complaints, plans that improperly denied claims, and concerns about marketing practices which do not follow government guidelines.
|
From:janis123
Views:2274
 6ratings
|
| Time:07:51 | More inNews & Politics |
Rx Drug Compare
Translator
By N2H